The journal and authors retract the article cited above for the following reasons provided by the authors:
The authors state “We cannot repeat some of the biological results of this article, which directly leads to our inability to carry out follow-up research. Based on the above objective reasons, after careful discussion and consideration, our team decided to withdraw the manuscript in a rigorous and scientific attitude”.
This retraction, as requested by the authors, was approved by the Editors-in-Chief of the Journal.
Summary
Keywords
retraction, PORE, POR, Pathology, oncology
Citation
Pathology & Oncology Research Editorial Office (2021) Retraction: MiR-424-5p Inhibits Proliferation, Invasion and Promotes Apoptosis and Predicts Good Prognosis in Glioma by Directly Targeting BFAR. Pathol. Oncol. Res. 27:1609970. doi: 10.3389/pore.2021.1609970
Received
19 July 2021
Accepted
19 July 2021
Published
23 August 2021
Volume
27 - 2021
Updates
Copyright
© 2021 Pathology & Oncology Research Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pathology & Oncology Research Editorial Office, editorialoffice@por-journal.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.